Skip to content

Electrophysiological Biomarkers in MTLE Patients.

Electrophysiological Biomarkers During Invasive Monitoring of Mesial Temporal Lobe Epilepsy Patients.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04710004
Enrollment
1
Registered
2021-01-14
Start date
2021-11-30
Completion date
2021-12-16
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mesial Temporal Lobe Epilepsy

Keywords

Epilepsy, Biomarkers

Brief summary

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

Detailed description

This is a nonrandomized interventional trial that will apply brain stimulation via clinically implanted intracranial electrodes to subjects with medial temporal lobe epilepsy with the purpose of identifying biomarkers related to the pre-ictal state; to perform an acute parameter search to determine the stimulation pattern that most effectively modifies these biomarkers and to identify changes in memory (free recall) during asynchronous distributed multi-electrode stimulation (ADMES).

Interventions

DEVICEAsynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device

Participants will receive asynchronous pulses distributed across a multi-electrode array of 16 micro-electrodes and stimulating at low (theta) frequencies.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Provision of signed and dated informed consent form 2. Male or female, aged 18-65 3. Diagnosed with lesional or non-lesional mesial temporal (hippocampal) seizure onset confirmed on SEEG monitoring 4. Implanted with depth electrodes for localization of seizure onset with multiple hippocampal electrode arrays

Exclusion criteria

1. Any patient who is unwilling or unable to provide consent 2. Women who are pregnant 3. Patients under 18 years 4. Incarcerated persons

Design outcomes

Primary

MeasureTime frameDescription
Change in Intracranial EEG Recording: Spectral Power From BaselineBaseline, up to 6 weeks postinterventionSpectral power will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates spectral power during the preictal, ictal or post ictal states. Spectral power is measured in microvolts. A change in either direction from baseline is associated with a better outcome.
Change in Intracranial EEG Recording: Synchrony From BaselineBaseline, up to 6 weeks postinterventionSynchrony will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates synchrony during the preictal, ictal or post ictal states. Synchrony is a measure of how any pair of regions communicate with one another. Synchrony is measured as the correlation \[-1 to 1\] between two time series. The investigators anticipate that a decrease in synchrony (correlation approaching 0) is associated with improved outcome.

Secondary

MeasureTime frameDescription
Changes in Memory During Brain Stimulation From BaselineBaseline, up to 6 weeks postinterventionPatients will be asked to recall a list of words after a 20-second delay in which they will do simple math problems to ensure long-term memory encoding. Three \ 1-2-hour sessions will be performed; each session will consist of 24 free recall tasks (12 during ADMES and 12 with no stimulation). The memory score will be assessed as the percentage correct out of 12. The higher the percentage recalled, the better the score.

Countries

United States

Participant flow

Participants by arm

ArmCount
Brain Stimulation Via Clinically Implanted Electrodes
Brain will be stimulated in different patterns including synchronized or asynchronous current. Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device: Participants will receive asynchronous pulses distributed across a multi-electrode array of 16 micro-electrodes and stimulating at low (theta) frequencies.
1
Total1

Baseline characteristics

CharacteristicBrain Stimulation Via Clinically Implanted Electrodes
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
0 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Change in Intracranial EEG Recording: Spectral Power From Baseline

Spectral power will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates spectral power during the preictal, ictal or post ictal states. Spectral power is measured in microvolts. A change in either direction from baseline is associated with a better outcome.

Time frame: Baseline, up to 6 weeks postintervention

Population: No data collected. Subject was discharged before testing could be completed.

Primary

Change in Intracranial EEG Recording: Synchrony From Baseline

Synchrony will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates synchrony during the preictal, ictal or post ictal states. Synchrony is a measure of how any pair of regions communicate with one another. Synchrony is measured as the correlation \[-1 to 1\] between two time series. The investigators anticipate that a decrease in synchrony (correlation approaching 0) is associated with improved outcome.

Time frame: Baseline, up to 6 weeks postintervention

Population: No data collected. Subject was discharged before testing could be completed.

Secondary

Changes in Memory During Brain Stimulation From Baseline

Patients will be asked to recall a list of words after a 20-second delay in which they will do simple math problems to ensure long-term memory encoding. Three \ 1-2-hour sessions will be performed; each session will consist of 24 free recall tasks (12 during ADMES and 12 with no stimulation). The memory score will be assessed as the percentage correct out of 12. The higher the percentage recalled, the better the score.

Time frame: Baseline, up to 6 weeks postintervention

Population: No data collected. Subject was discharged before testing could be completed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026